Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors
Clinical trial NCT00698841 · COMPLETED
Trial details
- NCT number
- NCT00698841
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-02-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.